FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1488353016> ?p ?o ?g. }

• W1488353016 endingPage "2485" @default.
• W1488353016 startingPage "2485" @default.
• W1488353016 abstract "Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro Tonglie Huang,1,* Kuo Zhang,2,* Lijuan Sun,3 Xiaochang Xue,1 Cun Zhang,1 Zhen Shu,1 Nan Mu,1 Jintao Gu,1 Wangqian Zhang,1 Yukun Wang,1 Yingqi Zhang,1 Wei Zhang1 1State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Pharmacy, The Fourth Military Medical University, 2National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University, 3Department of Ophthalmology, Xijing Hospital, The Fourth Military Medical University, Xi’an, People’s Republic of China *These authors contributed equally to this work Abstract: Chemical burns take up a high proportion of burns admissions and can penetrate deep into tissues. Various reagents have been applied in the treatment of skin chemical burns; however, no optimal reagent for skin chemical burns currently exists. The present study investigated the effect of topical body protective compound (BPC)-157 treatment on skin wound healing, using an alkali burn rat model. Topical treatment with BPC-157 was shown to accelerate wound closure following an alkali burn. Histological examination of skin sections with hematoxylin–eosin and Masson staining showed better granulation tissue formation, reepithelialization, dermal remodeling, and a higher extent of collagen deposition when compared to the model control group on the 18th day postwounding. BPC-157 could promote vascular endothelial growth factor expression in wounded skin tissues. Furthermore, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and cell cycle analysis demonstrated that BPC-157 enhanced the proliferation of human umbilical vein endothelial cells (HUVECs). Transwell assay and wound healing assay showed that BPC-157 significantly promoted migration of HUVECs. We also observed that BPC-157 upregulated the expression of VEGF-a and accelerated vascular tube formation in vitro. Moreover, further studies suggested that BPC-157 regulated the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1/2) as well as its downstream targets, including c-Fos, c-Jun, and Egr-1, which are key molecules involved in cell growth, migration, and angiogenesis. Altogether, our results indicated that BPC-157 treatment may accelerate wound healing in a model of alkali burn-induced skin injury. The therapeutic mechanism may be associated with accelerated granulation tissue formation, reepithelialization, dermal remodeling, and collagen deposition through ERK1/2 signaling pathway. Keywords: pentadecapeptide BPC-157, wound healing, human umbilical vein endothelial cells, ERK1/2 signaling pathway" @default.
• W1488353016 created "2016-06-24" @default.
• W1488353016 creator A5007143963 @default.
• W1488353016 creator A5020972239 @default.
• W1488353016 creator A5023061114 @default.
• W1488353016 creator A5030702585 @default.
• W1488353016 creator A5031783842 @default.
• W1488353016 creator A5032460787 @default.
• W1488353016 creator A5037793935 @default.
• W1488353016 creator A5047903038 @default.
• W1488353016 creator A5048753910 @default.
• W1488353016 creator A5061582301 @default.
• W1488353016 creator A5074313030 @default.
• W1488353016 creator A5076403164 @default.
• W1488353016 date "2015-04-01" @default.
• W1488353016 modified "2023-10-16" @default.
• W1488353016 title "Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro" @default.
• W1488353016 cites W1943600015 @default.
• W1488353016 cites W1974395237 @default.
• W1488353016 cites W1975991554 @default.
• W1488353016 cites W1976708157 @default.
• W1488353016 cites W1987409883 @default.
• W1488353016 cites W1992156646 @default.
• W1488353016 cites W1996295468 @default.
• W1488353016 cites W1997798902 @default.
• W1488353016 cites W2002160125 @default.
• W1488353016 cites W2004185349 @default.
• W1488353016 cites W2012457741 @default.
• W1488353016 cites W2021530697 @default.
• W1488353016 cites W2030706250 @default.
• W1488353016 cites W2034960421 @default.
• W1488353016 cites W2042811173 @default.
• W1488353016 cites W2046172352 @default.
• W1488353016 cites W2048260185 @default.
• W1488353016 cites W2048474932 @default.
• W1488353016 cites W2050879337 @default.
• W1488353016 cites W2056536841 @default.
• W1488353016 cites W2067927054 @default.
• W1488353016 cites W2069594072 @default.
• W1488353016 cites W2069656614 @default.
• W1488353016 cites W2076341329 @default.
• W1488353016 cites W2078072567 @default.
• W1488353016 cites W2078774344 @default.
• W1488353016 cites W2081463073 @default.
• W1488353016 cites W2082614630 @default.
• W1488353016 cites W2085293124 @default.
• W1488353016 cites W2091094644 @default.
• W1488353016 cites W2096031257 @default.
• W1488353016 cites W2101293486 @default.
• W1488353016 cites W2101775253 @default.
• W1488353016 cites W2102638227 @default.
• W1488353016 cites W2115047729 @default.
• W1488353016 cites W2142256223 @default.
• W1488353016 cites W2161579722 @default.
• W1488353016 cites W2165661552 @default.
• W1488353016 cites W2166984911 @default.
• W1488353016 cites W2171878526 @default.
• W1488353016 cites W2419461484 @default.
• W1488353016 cites W277208132 @default.
• W1488353016 doi "https://doi.org/10.2147/dddt.s82030" @default.
• W1488353016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4425239" @default.
• W1488353016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25995620" @default.
• W1488353016 hasPublicationYear "2015" @default.
• W1488353016 type Work @default.
• W1488353016 sameAs 1488353016 @default.
• W1488353016 citedByCount "69" @default.
• W1488353016 countsByYear W14883530162014 @default.
• W1488353016 countsByYear W14883530162015 @default.
• W1488353016 countsByYear W14883530162016 @default.
• W1488353016 countsByYear W14883530162017 @default.
• W1488353016 countsByYear W14883530162018 @default.
• W1488353016 countsByYear W14883530162019 @default.
• W1488353016 countsByYear W14883530162020 @default.
• W1488353016 countsByYear W14883530162021 @default.
• W1488353016 countsByYear W14883530162022 @default.
• W1488353016 countsByYear W14883530162023 @default.
• W1488353016 crossrefType "journal-article" @default.
• W1488353016 hasAuthorship W1488353016A5007143963 @default.
• W1488353016 hasAuthorship W1488353016A5020972239 @default.
• W1488353016 hasAuthorship W1488353016A5023061114 @default.
• W1488353016 hasAuthorship W1488353016A5030702585 @default.
• W1488353016 hasAuthorship W1488353016A5031783842 @default.
• W1488353016 hasAuthorship W1488353016A5032460787 @default.
• W1488353016 hasAuthorship W1488353016A5037793935 @default.
• W1488353016 hasAuthorship W1488353016A5047903038 @default.
• W1488353016 hasAuthorship W1488353016A5048753910 @default.
• W1488353016 hasAuthorship W1488353016A5061582301 @default.
• W1488353016 hasAuthorship W1488353016A5074313030 @default.
• W1488353016 hasAuthorship W1488353016A5076403164 @default.
• W1488353016 hasBestOaLocation W14883530161 @default.
• W1488353016 hasConcept C125473707 @default.
• W1488353016 hasConcept C141071460 @default.
• W1488353016 hasConcept C142724271 @default.
• W1488353016 hasConcept C150903083 @default.
• W1488353016 hasConcept C185592680 @default.
• W1488353016 hasConcept C207001950 @default.
• W1488353016 hasConcept C2776055305 @default.
• W1488353016 hasConcept C2780269544 @default.

• next